Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

First Patent Granted for ExtendT Technology

4 Feb 2013 07:00

RNS Number : 9936W
TyraTech, Inc.
04 February 2013
 

4 February 2013

TyraTech, Inc.

(the "Company" or "TyraTech")

TyraTech Announces first patent granted for its Extend™ Technology

 

TyraTech Inc (AIM: TYR and TYRU), a life sciences company focusing on natural pest control and healthcare products, has received notification that its Extend™ patent has been granted in South Africa. The patent proves the proprietary nature of the Company's technology platform and protects a broad range of synergistic combinations of natural and synthetic compounds, which can be used against a variety of target pests. The patent has a 20-year term, which expires in March 2029.

Bruno Jactel, CEO, said: "These patents are important to demonstrate the synergy between our blends and synthetic compounds and that we are uniquely able to improve the efficacy while reducing the environmental footprint of synthetic pesticides. This will support both the strategy of ENVANCE Technologies, our joint venture with AMVAC Chemical Corporation and our animal health strategy."

 

 

For further information please contact:

 

TyraTech Inc.

Alan Reade, Executive Chairman

Tel: +1 919 415 4310

Bruno Jactel Chief Executive Officer

Tel: +1 919 415 4340

N+1 Singer, Nominated Adviser and Joint Broker

Tel: +44 20 7496 3000

Aubrey Powell / Alex Wright

First Columbus LLP, Joint Broker

Tel: +44 20 3002 2070

Chris Crawford

Walbrook, Financial PR and IR

Bob Huxford /Helen Westaway (Public Relations)

 

Tel + 44 20 7933 8792

tyratech@walbrookpr.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGGZZFFGFZZ

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS